| Literature DB >> 33322049 |
Federico Scali1, Giovanni Santucci1, Antonio M Maisano1, Francesca Giudici1, Federica Guadagno1, Matteo Tonni1, Alberto Amicabile1, Nicoletta Formenti1, Enrico Giacomini1, Massimiliano Lazzaro1, Giorgio Bontempi1, Nicoletta Vitale2, Lis Alban3, Jeroen Dewulf4, Adriana Ianieri5, Sergio Ghidini5, Giancarlo Belluzzi5, Loredana Candela6, Angelica Maggio6, Paolo Pasquali7, Silvio Borrello6, Giovanni L Alborali1.
Abstract
Data on antimicrobial use (AMU) in heavy pig production (>150 kg) are limited. The aim of this study was to investigate the AMU in this production. Data from 2015 were collected for 143 fattening farms. The AMU was estimated through a treatment index per 100 days (TI100) using the defined daily dose animal for Italy (DDDAit). When possible, a comparison with the European Medicines Agency's defined daily doses for animals (DDDvet) was performed. The median TI100 was 10.7 (range, 0.2-49.5). Group treatments represented 94.6% of overall consumption. The AMU calculated using DDDAit and DDDvet were strongly correlated (ρ = 0.976; p < 0.001). The AMU was negatively correlated with injectables use (ρ = -0.46, p < 0.001) and positively correlated with oral products (ρ = 0.21, p = 0.014), premixes (ρ = 0.26, p = 0.002), and mortality (ρ = 0.18; p = 0.027). Farm size was negatively correlated with AMU (ρ = -0.29, p < 0.001). Smaller farms were more frequently above the median TI100 (odds ratio = 2.3, 95% confidence interval = 1.2-4.7), suggesting that they may have lower biosecurity and management standards. The results of this study should provide useful insights for the development of an Italian monitoring system.Entities:
Keywords: AMU; DDDAit; DDDvet; mortality; pig production; prudent use; swine
Year: 2020 PMID: 33322049 PMCID: PMC7764202 DOI: 10.3390/antibiotics9120892
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382